Through the years, we can see that some diabetes medications, like metformin, are often prescribed with a percentage of 90% or above in all the visits; the SGLT2 inhibitors and DPP IV inhibitors were increased in the prescriptions from a percentage of 5% and 14% respectively to 25% of both. The gene discussed is SLC5A2; the disease is diabetes mellitus.